Literature DB >> 5132112

L-3,4-dihydroxyphenylalanine metabolism by the gut in vitro.

L Rivera-Calimlim, J P Morgan, C A Dujovne, J R Bianchine, L Lasagna.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5132112     DOI： 10.1016/0006-2952(71)90109-2

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  11 in total

1.  The role of the liver in the clearance of l-dope from plasma.

Authors:  P T Mearrick; G G Graham; D N Wade
Journal:  J Pharmacokinet Biopharm       Date:  1975-02

2.  Plasma dopa concentrations after different preparations of levodopa in normal subjects.

Authors:  J G Morris; R L Parsons; J R Trounce; M J Groves
Journal:  Br J Clin Pharmacol       Date:  1976-12       Impact factor: 4.335

3.  Intestinal decarboxylation of L-Dopa in relation to dose requirement in Parkinson's disease.

Authors:  A K Granerus; R Jagenburg; A Svanborg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

4.  Decarboxylation of orally administered L-dopa in the human digestive tract.

Authors:  J Bergmark; A Carlsson; A K Granerus; R Jagenburg; T Magnusson; A Svanborg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

Review 5.  Clinical pharmacokinetics of anti-parkinsonian drugs.

Authors:  J M Cedarbaum
Journal:  Clin Pharmacokinet       Date:  1987-09       Impact factor: 6.447

Review 6.  Clinical pharmacokinetics of levodopa in parkinson's disease.

Authors:  J R Bianchine; G M Shaw
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

7.  An improved fluorimetric method for assay of dopa in urine and tissues and its use for determination of urinary dopa, at endogenous level, in different species.

Authors:  J M Cottet-Emard; L Peyrin
Journal:  J Neural Transm       Date:  1977       Impact factor: 3.575

Review 8.  Rectal drug administration: clinical pharmacokinetic considerations.

Authors:  A G de Boer; F Moolenaar; L G de Leede; D D Breimer
Journal:  Clin Pharmacokinet       Date:  1982 Jul-Aug       Impact factor: 6.447

9.  Drug metabolism by the gastrointestinal mucosa.

Authors:  C F George
Journal:  Clin Pharmacokinet       Date:  1981 Jul-Aug       Impact factor: 6.447

10.  The effects of carbidopa dose and time and route of administration on systemic L-dopa levels in rats.

Authors:  P S Leppert; M Cortese; J A Fix
Journal:  Pharm Res       Date:  1988-09       Impact factor: 4.200
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.